New PET scan agent could spot kidney cancer more accurately
NCT ID NCT06680089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new radioactive imaging agent called [18F]RCCB6 for PET/CT scans to see if it can better detect kidney cancer, especially the most common type, clear cell renal cell carcinoma. Researchers will enroll 300 adults with confirmed or suspected kidney cancer. The goal is to see how the agent spreads in the body and how well it identifies tumors compared to standard scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [18F]RCCB6 (a radioactive imaging agent)
- What this could lead to
- If successful, this could provide a more accurate, non-invasive way to detect and monitor kidney cancer, potentially reducing the need for biopsies.
- What could go wrong
- This is a phase 2 trial with 300 participants, so it is still early. The imaging agent may not prove significantly better than existing methods, and its availability may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
RECRUITINGShanghai, Shanghai Municipality, 200127, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a simple text message transform cancer care?
- Can modern Radiotherapy's late effects be predicted?
- Can a Two-Pronged immune attack shrink kidney tumors before surgery?